drugset / Trial / NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
Phase 2
Terminated
13 enrolled
The Emmes Company, LLC
National Heart, Lung, and Blood Institute (NHLBI) · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the addition of parathyroid hormone after a sequential cord blood transplant will improve engraftment, which is the ability of the transplanted stem cells to grow and to successfully begin producing new blood cells.
Timeline
- Start
- 2006-09
- Primary completion
- 2009-11
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 100 ug | — |